Cirius Therapeutics Competitors and Similar CompaniesClear all
Cirius Therapeutics's competitors and similar companies include CSL Behring and Ipsen.
 Cirius Therapeutics Cirius Therapeutics, a clinical-stage pharmaceutical company which is developing a next-generation insulin sensitizer for the treatment of nonalcoholic steatohepatitis. | |||
Founding Date | Founding Date 2016 | Founding Date 1904 | Founding Date 1929 |
Type | Type Private | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Kalamazoo, US HQ San Diego, US | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more |
Employees | Employees N/A | Employees 7,5692% decrease | Employees 5,358 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) €3.7b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $4.5b (FY, 2020) | Gross profit €3.3b (FY, 2025) |
For sources of this data, please see the company profile